Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology
- PMID: 11231486
- DOI: 10.5858/2001-125-0375-HFOZ
Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology
Abstract
Objective: Invasive zygomycosis is rapidly progressive and is associated with angioinvasion and infarction. Invasive disease requires emergent surgical and medical intervention. Because it is important for surgical pathologists to recognize these fungi and their preferential sites of growth, the objective of this article is to describe the fungal morphology and histopathologic findings in biopsies from patients with zygomycotic disease, with emphasis on preferential sites of fungal growth.
Design: Medical record and histologic review identified 20 patients with zygomycosis. Inclusion criteria included the presence of typical ribbonlike hyphae and positive culture, a clinical history of invasive zygomycosis, or both. The histologic features of disease and the fungal morphology were assessed.
Results: Fungus ball (15%), rhinocerebral (55%), and pulmonary (30%) disease were the types of disease represented. The inflammatory responses were predominantly neutrophilic (50%), predominantly granulomatous (5%), pyogranulomatous (25%), or absent (20%). Invasive disease was characterized by prominent infarcts (94%), angioinvasion (100%), and, surprisingly, prominent perineural invasion (90%) in biopsies that contained nerves for evaluation. At least rare hyphal septa were always seen (100%), and most branches (95%) varied from 45 degrees to 90 degrees.
Conclusions: As known to mycologists, zygomycetes are pauciseptate, rather than aseptate, molds. Therefore, the presence of an occasional septum is expected. Perineural invasion is a common finding in invasive zygomycosis, as are angioinvasion and infarcts. Therefore, prior to excluding the presence of these fungi in biopsies suspected to contain zygomycetes, the perineural space should be carefully examined.
Similar articles
-
Rhinocerebral mucormycosis: Pathology revisited with emphasis on perineural spread.Neurol India. 2014 Jul-Aug;62(4):383-6. doi: 10.4103/0028-3886.141252. Neurol India. 2014. PMID: 25237943
-
Zygomycotic necrotizing fasciitis in immunocompetent patients: a series of 18 cases.Mod Pathol. 2006 Sep;19(9):1221-6. doi: 10.1038/modpathol.3800639. Epub 2006 Jun 2. Mod Pathol. 2006. PMID: 16741524
-
[Clinicopathologic study of invasive fungal rhinosinusitis caused by Aspergillus and Mucorales].Zhonghua Bing Li Xue Za Zhi. 2012 Oct;41(10):662-6. doi: 10.3760/cma.j.issn.0529-5807.2012.10.004. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 23302306 Chinese.
-
Chapter 7: zygomycosis.J Bras Pneumol. 2010 Jan-Feb;36(1):134-41. doi: 10.1590/s1806-37132010000100018. J Bras Pneumol. 2010. PMID: 20209316 Review. English, Portuguese.
-
Zygomycosis: conventional laboratory diagnosis.Clin Microbiol Infect. 2009 Oct;15 Suppl 5:60-5. doi: 10.1111/j.1469-0691.2009.02999.x. Clin Microbiol Infect. 2009. PMID: 19754760 Review.
Cited by
-
Utility of MGG and Papanicolaou stained smears in the detection of Mucormycosis in nasal swab/scraping/biopsy samples of COVID 19 patients.Diagn Cytopathol. 2022 Mar;50(3):93-98. doi: 10.1002/dc.24924. Epub 2021 Dec 29. Diagn Cytopathol. 2022. PMID: 34967146 Free PMC article.
-
Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic.Folia Microbiol (Praha). 2022 Jun;67(3):363-387. doi: 10.1007/s12223-021-00934-5. Epub 2022 Feb 26. Folia Microbiol (Praha). 2022. PMID: 35220559 Free PMC article. Review.
-
Bronchial wall necrosis secondary to mucormycosis following SARS-Cov2 infection: A case report.Radiol Case Rep. 2022 Jun 17;17(9):2956-2959. doi: 10.1016/j.radcr.2022.05.049. eCollection 2022 Sep. Radiol Case Rep. 2022. PMID: 35747739 Free PMC article.
-
Mucormycosis in COVID-19 patients: predisposing factors, prevention and management.Acta Neurol Belg. 2022 Apr;122(2):273-280. doi: 10.1007/s13760-021-01840-w. Epub 2021 Nov 24. Acta Neurol Belg. 2022. PMID: 34820787 Free PMC article. Review.
-
Posaconazole as salvage therapy for zygomycosis.Antimicrob Agents Chemother. 2006 Jan;50(1):126-33. doi: 10.1128/AAC.50.1.126-133.2006. Antimicrob Agents Chemother. 2006. PMID: 16377677 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials